Grants Dashboard

The goal of the New Jersey State Opioid Response (NJ-SOR) is to address the opioid crisis confronting the state using a variety of strategies. The key objectives are to increase access to medication assisted treatment (MAT), reduce unmet treatment need and reduce opioid related deaths. To address these objectives, the New Jersey Division of Mental Health and Addiction Services (DMHAS) will develop infrastructure support to provide buprenorphine in standard outpatient and intensive outpatient substance use disorder (SUD) treatment as well as a low-threshold buprenorphine induction program. A new mobile van pilot program will be developed to facilitate low induction medication, case management and other ancillary services for individuals with an opioid use disorder (OUD) in communities with low access to MAT and high rates of homelessness. Additionally, a program will be developed to enhance overall recovery in stimulant use disorders utilizing contingency management. A public information, education, and training campaign will be launched to reduce discrimination and promote MAT as the evidence-based practice (EBP) for OUD. Additionally, opportunities for training, professional development and wellness services will be developed for OUD treatment professionals, as well as, recovery service workers. Prevention efforts will include expanding the target groups that receive naloxone training and kits through the Robert Wood Johnson Medical School and Opioid Overdose Prevention Program (OOPP), as well as, expanding the availability of naloxone kits to high risk populations through partnerships with New Jersey's seven Harm Reduction Centers and statewide distribution events. Recovery activities will include a continuation of the Opioid Overdose Recovery Programs (OORP) and the Support Team for Addiction Recovery programs (STAR). Anticipated outcomes of the SOR include: reduction/abstinence from drugs and alcohol, increase in employment, reduced criminal justice involvement, increased social connectedness, and increased percentage of individuals completing treatment at the recommended level of care. Additional outcomes include: reducing opioid overdoses, increasing retention in treatment, reducing the length of time to relapse and prolonging recovery, and increasing number of individuals receiving MAT. It is estimated that SOR will serve 34,178 individuals during the first year and 68,356 individuals over the two-year project.

For the first time since 2014 opioid-related fatalities in Vermont decreased by 15 % from 2018 to 2019. Cocaine was present in 43% of the fatalities. These results are encouraging and demonstrate a continuing need for a comprehensive public health approach. The State Opioid Response proposes to help Vermonters access treatment and move from treatment to successful recovery through strengthened prevention, treatment, and recovery services. Populations of focus are: 1) individuals who are in need of but not actively seeking opioid use disorder (OUD) treatment; 2) individuals awaiting administration of Medication Assisted Treatment (MAT); and 3) individuals who may be at increased risk for opioid overdose, including those using both cocaine and opioids. We plan to embark on a set of SOR year three activities that capitalize on enhanced and mutually reinforcing initiatives implemented through existing prevention, treatment, and recovery systems. Goal One: increase access to OUD treatment, including MAT. Supported activities: VT Helplink call center information, support and referral services; ASAM Level 3.1 residential treatment program implementation; adolescent and family screening, engagement, and recovery services. Goal Two: increase regional capacity to implement community-specific opioid strategies. Activities include: community needs assessment, training, media coordination and funding of community initiatives to prevention OUD; education and referral services to new Americans at risk of OUD; enhanced recovery supports such as specialized recovery coaching for pregnant and parenting women, transitional housing, employment specialists, legal assistance, and recovery coaches embedded in nine regional hospital emergency departments. Goal Three: decrease opioid related deaths. In addition to the interventions already described, activities include: distribution of overdose reversal drug Naloxone and treatment resource information materials (Harm Reduction to-go Packs) through community organizations serving high risk populations and their families; reduced access to unused prescription pain relievers through collection and storage of unused prescription drugs. Note: Estimated numbers served includes proposed prevention, intervention and recovery services.

Despite the prevalence of poverty, low reporting capacity, health disparities etc. Mississippi has made great strides in combating substance use disorders (SUDs), in a relatively short time frame. Supported by SAMHSA’s State Targeted Response (STR) and State Opioid Response (SOR), Mississippi has achieved the following outcomes: increased access to treatment; increased availability and decreased stigma of Medication Assisted Treatment (MAT); increased implementation of evidence-based treatment; increased public awareness; increased capacity for and availability of Narcan; increased partnerships and collaboration among state agencies and with community-based organizations; improved state-level infrastructure; and reduced duplication of services between public agencies. At the very onset of the MS STR/SOR Projects, a paradigm shift was past due among the State’s Community Level Service Providers and First Responders. Many providers were of the mindset that MAT was merely a substitute of one addiction for another one. This type of thinking promoted abstinence as the only true means of recovery. At the same time, many law enforcement agencies and emergency response entities were of a mindset that was reluctant to concepts that called for the administering of overdose reversal medications. This culture subscribed to a thought process that suggested that there is little need to waste time, effort and/or resources on addicts that were a drain on society and would likely die eventually from another overdose, a high-risk lifestyle or complication related to addiction. It was through SAMHSA’s STR/SOR that Mississippi was afforded education and awareness resources, such as Stand-Up-Mississippi, Town Hall Meetings and increased services, that our state began to gain leverage on the SUD Crisis. Efforts such as these will allow MS to further reduce OSUDs during 2020-2022. The 2020 MS-SOR/SOR II will take aim at the remaining challenges and gaps. Best practices during SOR II will reduce re-occurrence of service gaps. The proposed project will target an estimated 11,500 Mississippians through: (1) prevention of Opioid and/or Stimulant Use Disorders (OSUDs) for persons under 18; (2) treatment and recovery for adults with OSUDs; (3) infrastructure enhancements. The identified geographic catchment area will be the entire state. Community Mental Health Centers and free-standing prevention and treatment programs cover all 82 counties. Prevention services will target school-aged youth in grades 3-8. The treatment and recovery component will target adults over 18 with OSUDs. Funding made available by SOR II will supplement and not supplant existing opioid prevention, treatment, and recovery activities. Funding goals, objectives, and plans will be cross-referenced for duplication to include COVID-19-related funding (NOA received), the Substance Abuse Block Grant (SABG), state funding, and discretionary substance abuse prevention grants. DMH will utilize a competitive submission process whereby proposals are solicited, scored, and reviewed using a rating matrix developed directly from the requirements specified in the SAMHSA SOR 2020 FOA and further defined by DMH.

The overarching goal of the Arizona State Opioid Response project is to increase access to MAT treatment, coordinated and integrated care, OUD/stimulant use disorder recovery support services and prevention activities to reduce the prevalence of OUDs, stimulant use disorder and opioid-related overdose deaths. The project approach includes developing and supporting state, regional, and local level collaborations and service enhancements to develop and implement best practices to comprehensively address the full continuum of care related to opioid misuse, abuse and dependency. The proposed activities within the Arizona Opioid State Opioid Response project will work synergistically with existing efforts to reduce stimulant use disorder, OUDs and opioid-related deaths by: (1) sustaining and enhancing naloxone distribution; (2) increasing localized community prevention efforts; (3) expanding navigation and access to MAT through 24/7 OTPs, Medication Units and extended hours OTPs; and (5) expanding access to recovery support services including housing, peer supports and supportive recovery programming. Measurable objectives to reduce stimulant use disorder, OUDs and opioid-related deaths will include: number of naloxone kits disseminated; MAT utilization and retention; use of the CSPMP; rates of opioid prescribing; rates of individuals in prescribed doses in excess of 50 MEDDs; community knowledge and prevention behavior; ED utilization; and rates of fatal and non-fatal overdose. Target population will, at minimum, serve: individuals re-entering the community from correctional settings; individuals in rural and isolated areas; individuals experiencing homelessness; tribal populations; veterans, military service members and military families; pregnant women and parents with OUD; individuals with physical disabilities and individuals who have experienced trauma, toxic stress or adverse childhood experiences (ACEs). The project will serve 250,000 unduplicated individuals between year one and year two under prevention activities and serve 7,908 unduplicated individuals with treatment and recovery services in year one and an additional 11,863 unduplicated individuals in year two, for a total project reach of 19,771 unduplicated individuals.

The Puerto Rico (PR) Mental Health and Anti-Addiction Services Administration (MHAASA) proposes a 2-year SOR to reduce opioid addiction and overdose. Under Prevention, Naloxone distribution and training to first responders including Correction Officers and SA Peers; use of PDMP Red Flags for education of patients, physicians and pharmacists; and take-back of controlled medications are proposed. Treatment and Recovery to SA adults will be enhanced with MAT, WRAP, ORP, and RSHT EBP's, including male and parenting offender with OUD. Goal 1 is to reduce opioid overdose incidence in adults with SUD by implementing EB community prevention interventions. Objectives include: distribution of Naloxone with training on use to prevent opioid deaths, to 1,000 first responders, Corrections Officers, and SA Peers, 200 inmates post release and 300 pharmacists, to reduce by at least 15% overdose events in PR. Goal 2 is to increase access for adults with OUD/ODU to FDA approved MAT treatment, including SA inmates. Objectives include: opening 3 new OTP's to give access to MAT to at least 100 new clients with OUD: integrating WRAP EBP to complement MAT for adults with OUD/OD in 8 current, and 3 new, OTP's plus 3 SA Residential Treatment Centers (two for men and one for women), and 5 Drug Court Offices; Implementing a Pilot Project of treatments with Naltrexone and injectable Buprenorphine for 70 adults with OUD/ODU from MHAASA's Detoxification Unit in San Juan, and in SANOS FQHC of Caguas and the Pitirre CBO in Bayamon using physicians with DATA waiver; Implementing an ORP for 60 adults with OUD of the Ponce-500 Correctional Institution with integrated MAT, linking 90% to post-release MAT with recovery support services, and improving parenting skills and family support foe parenting offenders; and Testing 200 newly admitted patients in SA treatment for HIV with referral of positives, and vaccinating 3,000 SA clients at risk of Hepatitis. Goal 3 is to ensure peer counseling and coaching with community support services such as housing to adults with OUD to reduce relapse and criminal re-incidence. Objectives includes: Capacitating and certifying 40 recovered SA adults as Peer Specialist to implement the RTSH EBP with 750 adults with OUD discharged/referred from treatment; Achieving that at least 5% of participants receive stable housing; Provide 160 new enrollees contingency incentives to remain in treatment. This results in a total of 750 trainees receiving Naloxone and education on its use to prevent opioid overdose events per year and 1,500 by project end. It results in a total of 945 adults with OUD/ODU receiving treatment enhanced with EBP's by project end (440 in YR 01); 40 SA peers certified (20 per year) to provide peer counseling and coaching and 750 (375 per year) recovering clients receiving recovery group and RTSH EBP support services. A total 160 (80 per year) of new enrollees will receive contingency incentives to address travel, food and other barriers to participation. An evaluation team will be used to collect, analyze, and report process and outcome data quarterly.

The purpose of Nebraska's State Opioid Response program is to substantially reduce the incidence of misuse of prescription opioids and reduce the use of illicit opioid and stimulant drugs in Nebraska through ongoing collaboration between practitioners, experts and leaders across the continuum of care. The program will also work to mitigate the effects of opioid use disorders (OUD), including both prescription opioids and illicit drugs, such as heroin, by identifying statewide needs, increasing access to treatment, including Medication Assisted Treatment (MAT), and reducing prescription drug overdose and stimulant use deaths through the provision of prevention, treatment and recovery activities. The Division of Behavioral Health (DBH) intends to serve 100 individuals in Year 1 of the grant and 120 individuals in Year 2. DBH will partner with other agencies to provide services to underserved populations statewide without duplicating efforts. Nebraska's goals include: assessing state and tribal opioid needs; implementing prevention initiatives including, opioid prescribing guidelines, opioid and stimulant awareness media campaigns, safe drug disposal initiatives, funding community coalitions to provide OUD and stimulant use prevention EBPs in communities of need, and provide Naloxone to at risk populations and providers; implementing clinically appropriate evidence-based practices (EBPs) for OUD and stimulant use treatment including training providers in the ECHO model, funding access to Naloxone, enhancing the utilization of MAT through the funding of Buprenorphine and providing training opportunities to the peer support curriculum specific to opioids and stimulants; and providing assistance to patients with treatment costs by providing funding for Buprenorphine. DBH intends to serve the entire population of the state through training and prevention initiatives, while targeting high burden areas of the state for outreach, training and technical assistance.

The purpose of North Dakota's SOR grant is to address the opioid crisis by increasing access to MAT, reduce unmet treatment need and reduce opioid overdose-related deaths through the provision of prevention, treatment and recovery activities. The state also intends to address stimulant misuse and use disorders through the provision of evidence-based prevention, treatment and recovery support services. Overdose deaths in North Dakota have increased from 20 deaths in 2013 to 77 deaths in 2016, then saw a decrease in 2017 of 68 according to the CDC/NCHA National Vital Statistics System, Mortality. The three OTPs in the state are serving 776 individuals as of May 1, 2020. A quarter (27.9%) of drug types seized in drug and narcotic violations in the state are stimulants (Crime in ND, 2018). According to the 2017-2018 NSDUH, 2.07% of North Dakotans ages 18-25 and 0.9% of North Dakotans ages 26 and older reported methamphetamine use in the past year. The first goal of ND's SOR grant is to decrease use/misuse of stimulants and opioids through the implementation of evidence-based primary prevention strategies. The following summarized objective was identified to achieve this goal: (1) implement Parents Lead and Opioids: Fill with Care campaign messages. The second goal is to prevent opioid overdose-related deaths by increasing implementation of evidence-based prevention strategies. The following, summarized objectives were identified to achieve this goal: (1) messaging related to evidence-based strategies to prevent opioid-overdose deaths; (2) increase the general public's access to naloxone. The third goal is to increase comprehensive evidence-based treatment and recovery services to support positive outcomes for individuals with an OUD and/or stimulant use disorder. The following summarized objectives were identified to achieve this goal: (1) implement comprehensive care coordination and recovery support services; (2) reduce barriers to treatment. Considering all goals and objectives above, the entire state population (755,393) has the potential to be reached throughout the grant period. This is mostly due to activities implemented to support the first and second goals. Because the state does not have a well-represented number for how many individuals have an OUD or stimulant use disorder, it is roughly estimated that 800 individuals will be served over the two-year grant period. Evaluation data will be collected to answer the evaluation questions posed in the FOA.

The Louisiana State Opioid Response (LaSOR) Project 2.0 will enhance existing statewide prevention, intervention, treatment, and recovery support services statewide for individuals with or at risk for opioid use disorder (OUD) or stimulant use/misuse (SUM).The priority populations to be served by this grant are: (1) the under- and uninsured, (2) the criminal justice population, (3) tribes, (4) pregnant women or women with infants experiencing neonatal opioid withdrawal symptoms, (5) people who inject drugs, (5) colleges and universities, and (6) school age children (for prevention). The goals of LaSOR 2.0 include: 1) Identify and address needs of state and federally-recognized tribes; 2) Decrease opioid and stimulant overdose death rates by increasing access to treatment services for the under- and uninsured with OUD or SUM; 3) Increase access to community recovery support services for patients with OUD or SUM; 4) Increase prevention, intervention, and education activities for opioid and stimulant use, misuse, and abuse; 5) Provide treatment transition and referral for patients reentering communities from criminal justice settings; and 6) Increase access to harm reduction strategies and linkage to HIV and viral hepatitis testing for priority populations. LaSOR 2.0 will provide a variety of services for 3,095 unduplicated individuals (1,355 in year one and 1,740 in year two). LaSOR 2.0 will expand and enhance the existing hub and spoke model, with Opioid Treatment Programs (OTPs) serving as hubs and Office Based Opioid Treatment (OBOT) providers serving as spokes. OBOT providers will receive support from Spoke Care Teams, education and consultation from Tulane University through academic detailing and Project ECHO, and psychiatric consults from Louisiana State University Health Sciences Center. In addition, the Mother-Baby Substance Exposure Initiative (MBSEI) will provide five birthing facilities with a patient navigator to connect identified women with treatment, resources, and providing social support as needed. Prevention and intervention strategies include education through the Prescription Drug Abuse Prevention Module of Life Skills Training, the Opioid Module of Project Alert and Generation Rx; safe storage and proper disposal of prescription medications; distribution of Narcan Kits to institutions of higher education, first responders, jails, and federally qualified health centers; faith based community partnerships; and a media campaign. OBH will host webinars and on-site trainings for healthcare professionals on opioid use, stimulant use and non-drug alternatives to pain management. In addition, peer trainings and webinars for institutions of higher education will be held. In addition, OUD in college students will be addressed through collegiate recovery programs and an evidence based substance use screening and assessment tool for university health centers. Community recovery support strategies include expansion of Oxford Houses statewide; Crisis Outreach Mobile Teams that will provide outreach services and mobile peer recovery services; placement of Peer Recovery Support Specialists in hospital emergency departments; and grief groups for families and loved ones who experienced a loss due to an opioid overdose. A pre-release opioid treatment program will be expanded in correction facilities to address OUD and SUM in the criminal justice population. In addition, Health Coordinators will be provided to Syringe Service Programs to expand harm reduction strategies and linkages to Hepatitis C and HIV testing. Finally, the needs of state and federally-recognized tribes will be identified through a thorough needs assessment and addressed through strategy implementation. This list of coordinated prevention, intervention, treatment, and recovery support services will increase Louisiana's capacity to address issues of opioid use across our state.

Alabama SOR is a statewide effort to reduce deaths related to opioid and stimulant overdose by 45% over the two-year project period. The project will continue to support efforts that have worked well in urban communities hardest hit by the epidemic, and expand the use of evidence-based practices and harm reduction strategies in rural communities that have limited resources to address growing substance use disorder problems. Project goals include: 1) lowering the opioid overdose death rate to 45% by 10/1/2022 by increasing the use of medication assisted treatment and evidence based treatment approaches to stimulant use; 2) lowering the opioid and stimulant overdose death rate by 45% by 10/1/2022 by reducing disparities in treatment and recovery support services accessibility; 3) expanding access to peer support services in targeted urban and rural communities; 4) improving data collection for opioid use disorders and stimulant use disorders, and using this data to enhance coordination of strategies and efforts across all state agencies in responding to this crisis; and 5) preventing new cases of opioid misuse by expanding community prevention efforts, including efforts that will increases the awareness of, and use of, naloxone. The project will implement five strategies to accomplish these goals: 1) expand access to Medication Assisted Treatment, particularly with populations, or in areas, where disparities in access exist or where opioid use disorders are most prevalent; 2) expand and enhance the use of telehealth technologies to increase access to substance use disorder treatment; 3) expand substance use prevention efforts that are consistent with the state’s Opioid Prevention Strategic Plan; 4) expand access to prevention, treatment and recovery activities for opioid use disorder (including illicit use of prescription opioids, heroin, fentanyl, and fentanyl analogs) and co-occurring conditions; and 5) expand access to prevention, treatment and recovery support services to address stimulant misuse and use disorders, including services for cocaine and methamphetamine use and co-occurring conditions. The project will serve 12,000 individuals annually and 24,000 throughout the two-year grant period. The project will be administered by the Alabama Department of Mental Health’s Division of Substance Abuse Services, which has been designated as the Single State Agency for SAMHSA SOR services.

NH Department of Human Services seeks this grant to strengthen and expand a comprehensive approach to address NH's opioid and substance use disorder epidemic through various prevention, treatment, and recovery services. NH intends to increase services for individuals with OUD/SUD statewide and to include stimulant misuse. While services will be made available to anyone seeking assistance in NH, special populations will be made a priority for some of the program designs including children and young adults, pregnant women, Veteran and service members, individuals with or at-risk for HIV/AIDS, older adults caring for a minor child due to DCYF involvement, and justice involved individuals and those re-entering the community post incarceration.

New York is a geographically, racially/ethnically, and socioeconomically diverse state of over 19 million residents. The populations of focus for New York's implementation if the State Opioid Response (SOR) II Grant are New Yorkers, located anywhere in the state, who: 1.a) have an untreated opioid use disorder (OUD) b) are at risk for developing an OUD; or c) are in recovery from an OUD; or 2.a) have an untreated stimulant use disorder b) are at risk for developing a stimulant use disorder; or c) are in recovery from a stimulant use disorder. New York proposed to build on past success by investing in services identified through regional networks that will oversee the continuation, and ongoing oversight of treatment-related projects as well as expand to fully integrate prevention and recovery services by supporting network and provider collaboration. The aim is to provide services across the continuum of care to create a wholistic approach to community intervention at the regional level. This includes utilizing measures to encourage network and provider collaboration to attain further increases in MAT initiation, MAT adherence, continuation of engagement in treatment, and continuity between levels of care, as well as demonstrably improved outreach to people who use opioids and/or stimulants who are not engaged in care. The network must also incorporate the full continuum of OASAS services by incorporating prevention and recovery into a more wholistic approach to community intervention. MAT in criminal justice settings and implementation of Contingency Management will also be areas of focus in enhancing treatment service to address opioid and stimulant disorder. Through regional networks, MAT in criminal justice settings and the implementation of contingency management OASAS will reach over 10,000 individuals per year with prevention, treatment and recovery services. Specific project reporting and GPRA data collection will be used to demonstrate the impact and effectiveness of this approach in improving patient outcomes.

While the number of opioid-related overdose deaths in Massachusetts has declined an estimated 5% from its peak in 2016, indicating smalls sign of progress; Massachusetts stills loses almost 2,000 people per year to opioid overdose with a number of high-risk populations and communities still disproportionally impacted. According to preliminary data, there were 2,023 confirmed and estimated opioid-related overdose deaths in 2019. Additionally, in the first nine months of 2019, cocaine was present in approximately 45% of opioid-related overdose deaths. With SOR funding the Massachusetts Department of Public Health (DPH), the applicant organization, will serve individuals affected by the opioid crisis including individuals who use stimulants, specifically targeting these high risk populations: communities of color, individuals who have experienced a prior overdose, youth and families impacted by the opioid crisis, persons with history of incarceration, pregnant and parenting women, individuals experiencing homelessness, individuals at risk of contracting and/or currently living with infectious disease, people who use stimulants alone and/or with other drugs, and persons with co-occurring disorders. MA DPH will ensure that funds are directed at the most marginalized populations and address systemic racial and ethnic disparities in access to SUD services. We seek to serve 11,200 individuals annually over the two-year project period through implementing the following activities: 1) Prevention and intervention services for youth and families; 2) Overdose prevention and harm reduction services including Post Overdose Support Teams to outreach to people who have overdosed; 3) Opioid Treatment Program (OTP)/Office-Based Opioid Treatment (OBOT) enhancements to increase access for historically underserved populations; 4) Expansion of opioid treatment access initiatives such as Hub and Spoke/Collaborative and Transitional Models of Care; 5) Treatment and recovery support services for individuals with criminal justice involvement that includes MAT induction, treatment and recovery planning; 6) Programming targeting pregnant and parenting women and their families that includes wrap-around supports, peer recovery coaching, and access to MAT; 7) Recovery supports including recovery housing, rapid rehousing, and the Access to Recovery program which facilitates client choice by providing voucher-based options and life skills training to support recovery goals; and 8) Expansion of developmentally appropriate recovery supports for youth and young adults. We also propose to: 9) Enhancements to existing state data analysis and reporting capabilities and improvements to web-based platforms to disseminate timely and accurate information to address the opioid crisis; 10) Implementation of wide-spread workforce development capacity building and training activities targeting a variety of sectors and audiences; and 11) Development and expansion of strategic communication and media campaigns targeting high-risk populations and high-need geographic regions in the Commonwealth to increase knowledge about addiction, decrease stigma, and improve awareness on how to prevent overdose and how to access treatment and recovery supports. We anticipate the MA SOR grant activities will improve, expand, and enhance access to opioid and/or stimulant use disorder treatment, prevent overdose, and support sustained recovery to achieve life-saving results.

The Montana State Opioid Response (SOR II) Project will support the implementation of evidence-based prevention, treatment, and recovery support strategies for individuals with Opioid and/or Stimulant Use Disorders (OUD and SUD) in Montana, with an emphasis on American Indians and individuals involved in the criminal justice system. American Indians are Montana's largest racial minority and face a more than 20-year disparity in life expectancy compared to white Montanans, partially attributable to higher rates of substance use. Justice system involvement for individuals with OUD and SUD is on the rise in Montana with an estimated 90% of the individuals in Montana jails being held for substance-abuse related offenses. Key strategies funded under this application include support for a comprehensive OUD treatment model at 16 provider locations in MT and providing technical assistance and training related to peer support, DATA Waivers, implementing MAT in justice system facilities, naloxone use, and the PAX Good Behavior Game. The goals and objectives for the MT SOR II projects are: Goal 1: Increase access to evidence-based treatment for underserved populations with OUD and SUD in Montana. Objective 1.1: By 8/31/2022, 1300 Montanans in clinically underserved group s will receive comprehensive OUD treatment services, including MAT, care coordination, behavioral health and peer support services, and HIV and Viral Hepatitis C testing. Objective 1.2: By 8/31/2022, 150 Montanans with methamphetamine or other stimulant use disorder will receive treatment services including contingency management, community reinforcement, and/or peer support. Objective 1.3: By 8/31/2022, a minimum of three detention centers will provide MAT and/or treatment transition services to individuals in or discharging from jail. Goal 2: Increase access to evidence-based prevention and recovery services for OUD and SUD in Montana. Objective 2.1: by 8/31/2022, 3500 naloxone units will be distributed to key partners including trained peer support specialists, First Responders, and Syringe Exchange Programs. By 8/31/2022, 50% of Montana grade schools will be trained to implement the PAX Good Behavior Game. Objective 2.3: By 8/31/2022, Montana will adopt standards, policies, and procedures to promote quality Recovery Housing. Goal 3: Enhance collaborations to increase the reach and impact of SOR activities statewide. Objective 3.1: By 8/31/2022, SOR leadership will meet four times with tribal health leaders to ensure effective coordination and appropriate implementation of SOR activities for Montana's American Indian population. Objective 3.2: By 8/31/2022, Montana will have a health communication plan to deliver evidence-based prevention and recovery messages to underserved populations. We plan to serve 1,450 unduplicated individuals throughout the two-year cycle; 700 in year one and 750 in year two. At this time, we expect to begin providing direct services by the third month after the grant is awarded.

Tennessee Department of Mental Health and Substance Abuse Services (TDMHSAS), will work to enhance current prevention, treatment, and recovery activities in response to the opioid epidemic through TN SOR II: Changing Behavior, Coordinating Care and Changing Lives. TN SOR II will increase access to medication-assisted treatment (MAT), reduce unmet treatment need due to OUD and/or stimulant disorder, and reduce opioid overdose-related deaths. TN SOR II populations of focus are individuals at high risk of overdose, individuals with a diagnosis of opioid use disorder, and individuals with a diagnosis of stimulant use disorder. The geographic catchment area for TN SOR II is the State of Tennessee. TDMHSAS estimates that it will serve 2,007 individuals who have an OUD and/or stimulant use disorder through treatment and recovery activities. TDMHSAS expects to serve 4,014 individuals through the duration of TN SOR II. TN SOR II aims to: (1) increase the dangers of opioids and stimulants and of opioid overdose prevention resources, (2) educate key stakeholders on preventing overdose and on safety around illicit drugs, (3) reduce the number of overdose-related deaths through naloxone distribution, (4) train health professionals to assess and treat individuals with an OUD and/or stimulant use disorder, (5) reduce opioid overdose deaths through an Emergency Department Initiated Buprenorphine/Naloxone Pilot Program, (6) Expand access to MAT in rural areas of the state, (7) expand access to MAT for recovery court clients through a pilot to provide injectable buprenorphine; and (8) expand access to MAT, clinical treatment and recovery services through a Hub and Spoke model. TDMHSAS has established measurable objectives to ensure progress towards these goals, including providing opioid overdose prevention trainings to stakeholders, distributing approximately 50,500 naloxone overdose prevention kits annually to individuals at high overdose risk and their families/peers, and partner with physicians to participate in a multimodal training (i.e.ECHO) to provide OUD and stimulant use disorder related educational opportunities to health professionals. TN SOR II will implement prevention, treatment and recovery interventions to ensure a multipronged comprehensive response to opioid and/or stimulant misuse. TDMHSAS will employ evidence-based practices (EBPs) including community-based naloxone distribution, and MAT, which when combined with other EBPS improves retention in treatment and reduces the risk of relapse.

The Colorado Department of Human Services, Office of Behavioral Health (OBH) proposes to address gaps in prevention, treatment and recovery services for opiate use disorders (OUD) through expansion of medication-assisted treatment (MAT); crisis and emergency services; naloxone distribution; residential treatment; sober living; peer supports; media campaigns; jail-based MAT and coordination with the criminal justice system. OBH estimates that nearly 44,000 individuals over the age of 18 are in need of treatment for OUD in Colorado, and existing services are unable to meet this need. This project will focus on these high-need populations, who face significant barriers: 1) uninsured/underinsured persons seeking MAT; 2) family members and children of individuals with OUD; 3) persons reentering the community from incarceration; 4) persons who interact with the emergency departments and the state crisis services; 5) persons with OUD who have infections from injecting drugs; and 6) high-utilizers of the criminal justice or emergency department services with unstable housing. Treatment data show the populations of focus are most likely to be 25-44, with males having a higher prevalence of heroin and no gender gap for prescription misuse. Less than 4% identify as LGBT, approximately 80% are White, and Hispanic populations represent 38% of the underinsured. Rural areas have the greatest gaps in care, especially west of the Rocky Mountains, while urban ares have the highest population in need of services. Identified gaps include access to affordable MAT and residential treatment, knowledge of naloxone and other resources to prevent overdose, connection to treatment following crisis, lack of family resources, gaps between the justice system and substance use disorder treatment, and access in tribal communities. Evidence-based strategies for addressing gaps include MAT funding for low-income uninsured patients; trainings for hospitalists, substance use providers, law enforcement, and tribal providers; prevention counseling for families; expanded capacity of crisis services; and a communications plan to reduce stigma. Project goals include prevention of OUD and overdose death; building recovery capital and support recovery services, support treatment access and services for people with OUD and or stimulant use disorder; and Government Performance and Results Act (GPRA) data collection and analysis to continue to improve the state systems. Outcome data include number of people receiving family resources, treatment, residential and recovery services, number of naloxone kits distributed, rates of opioid use and related deaths, and number of GPRAs linked to MAT. Over two years, grant activity goals will be to provide referral, family, prevention, treatment and recovery services for 4,800 individuals in Year 1 and 5,018 in Year 2, while also screening 4,800 people for HIV and viral hepatitis in each year of the grant. All together Colorado plans to serve 19,418 individuals across the life of the grant.

The Virgin Islands Department of Health State Opioid Response Grant will provide education, awareness and relief from overdose of prescription drugs and opioids.

The proposed State Opioid Response project aims to address the opioid and stimulant crisis in Nevada by increasing access to treatment, reducing unmet treatment need, and reducing opioid/stimulant overdose related deaths through the provision of prevention, treatment and recovery support activities for opioid use disorder and stimulant misuse. The complexity of the issues of opioid and stimulant use and addiction, both nationally and in Nevada, requires a multi-pronged approach that brings together prevention, early intervention, treatment, law enforcement, public policy, public health models, and recovery oriented systems of care. The crisis has highlighted continued opportunities for growth within state and local infrastructures that need to be brought together to develop a comprehensive, coordinated system of care. Nevadas vast geography and healthcare provider shortage contribute to a challenging environment to implement community-based strategies to combat the crisis. Stigma and lack of knowledge about available services continue to prevent individuals to seek treatment and physicians from linking and referring individuals to much needed opioid or stimulant use disorder treatment and recovery supports despite availability within treatment centers. Nevada has implemented a hybrid system of care to address the treatment needs for OUD Treatment and MAT Expansion. The following communities remain a of focus for State Opioid Response Grants (SOR) funding and includes: Pregnant and Post-partum women with OUD, and their newborns/dependents; Patients Reentering Communities from Criminal Justice, or other Rehabilitative Settings; Intravenous drug users and persons with OUD and co-morbidities, e.g. HIV/AIDS, Hepatitis C, and Tuberculosis; Veterans and Military personnel; and Aging Population with Intellectual and Developmental Disabilities. With this funding opportunity, Nevada will continue to address the unique needs of its communities and establish a long-term sustainable, coordinated, recovery-oriented system of care using the Collaborative Opioid Prescribing Model, overdose response and treatment engagement programs, overdose education and naloxone distribution, prescriber education and expansion of office based opioid treatment, recovery communities and peer supports, enhanced data collection, and information sharing between public health and law enforcement while maximizing existing resources including Medicaid reimbursement.

The District of Columbia's Opioid Response 2 (DCOR 2) initiative will focus on increasing access to medication-assisted treatment (MAT), reducing unmet treatment needs, and reducing opioid overdose-related deaths through the provision of prevention, treatment, and recovery support services (RSS) to individuals with opioid use disorder (OUD). Expanded services and supports will also be provided to individuals with stimulant use disorders (STUD). Through support from the first State Opioid Response (SOR) grant (DCOR 1), the District has increased access to MAT, including in the DC Jail, and has expanded the array of substance use disorder (SUD) treatment and RSS. The SOR 2 grant will continue many of these initiatives, but will increase entry points into the system of care (e.g., mobile screening and MAT in high need communities) and better coordinate care as individuals move through the system by supporting the development of a care management entity and care managers at the DC Jail. Care managers will guide individuals through assessment, stabilization, and a coordinated network of services and supports. Peer support specialists will be used throughout the continuum of care to foster engagement and service connection. Training, technical assistance, coaching, and consultation will be available to SUD providers/health care professionals to increase their ability to address client needs. In addition, the District will implement a coordinated approach at the community level by facilitating key stakeholders in each ward to work collaboratively around prevention, community outreach, and education initiatives. The DCOR 2 initiative will be implemented in all eight Wards with particular focus on Wards 5, 7 and 8 (highest opioid fatalities). A revised LIVE.LONG.DC, the District of Columbia Strategic Plan to Reduce Opioid Use, Misuse, and Related Deaths will be a guide for accomplishing the work. The specific goals of the grant are to continue to implement the city-wide opioid strategic plan; ensure timely access to high-quality (consistent with the criteria of the American Society of Addiction Medicine), coordinated, co-occurring (substance use disorder and mental health) treatment and recovery-oriented system of care; educate District residents and key stakeholders on the risk of opioid use disorders and stimulant addiction and effective prevention and treatment strategies; engage helping professionals and organizations in the prevention, early intervention and treatment of substance use disorder treatment through workforce development; support the awareness and availability of, and access to, harm reduction services in the District of Columbia consistent with evolving best and promising practices; implement a shared vision between the justice and public health agencies to address the needs of individuals who come in contact with the criminal justice system; and prepare for program sustainability through evaluation, planning, and performance monitoring and training and implement a continuous quality improvement process. The DCOR 2 initiative will serve 2,000 unduplicated individuals over the life of the grant (1,000 in Year 1 and 1,000 in Year 2).

The primary purpose of the proposed project is to design and implement a plan to further address the opioid crisis, founded on North Carolina's Opioid Action Plan 2.0, launched June 2019. The Action Plan aims to prevent, reduce harm and connect to care while focusing on several key areas: (1) Reduce the supply of inappropriate prescriptions and illicit opioids; (2) Prevent future opioid addiction by supporting children and families; (3) Advance harm reduction; (4) Address non-medical drivers of health and eliminate stigma; (5) Address the needs of justice-involved populations; (6) Expand access to treatment and recovery supports, and; (7) Track progress and measure impact. The focus of these SOR 2 funds will be on activities that can realistically be accomplished within the time frame of the grant. Additionally funding has been set aside in the budget to address individuals with or at risk of stimulant use disorder.

West Virginia will employ the State Opioid Response (SOR) grant statewide to address its opioid use crisis by expanding evidence-based prevention, treatment, and recovery management activities for Opioid Use Disorder (OUD). This includes increasing access to treatment with medication (MAT) in conjunction with counseling. Additionally, contingency management strategies will be implemented to treat individuals with stimulant use disorder. SOR funds will be utilized to address the state's MAT delivery and OUD continuum of care by using the hub-and-spoke strategy to increase MAT expertise and developing an array of identification, engagement, treatment, and MAT-friendly recovery services. Priority will be placed on high-risk populations, geographic areas hardest hit by the opioid crisis, and areas of need as identified by collected data. Number of people served is estimated as those directly impacted by prevention, early intervention, OUD/stimulant use treatment, and recovery management. Strategic social marketing and outreach will address the public, personal, and professional stigma which negatively impacts individuals seeking treatment.

The American Samoa State Opioid Response (AS SOR) project through its five (5) goals will address the need for treatment, recovery and prevention services for individuals with an Opioid Use Disorder and stimulant abuse. The five goals are basically to increase capacity to screen, increasing access to treatment services for at-risk populations, strengthening the healthcare providers capacity to offer Medication Assisted Treatment, reduce high-risk behaviors that could lead to opioid abuse/misuse, and development of recovery support services in the territory. The AS SOR proposes to use this funding to help strengthen the capacity throughout the service delivery system to be prepared and equipped with how to treat and prevent an OUD.

South Dakota's State Opioid Response will expand upon infrastructure and capacity built through the State Targeted Response and SOR efforts in support of increased access to medication-assisted treatment, life-saving naloxone distribution, telehealth access to care, and workforce development and training. Furthermore, the state will utilize SOR funding to address stimulant use in addition to opioid use. As the Single State Authority, the South Dakota Department of Social Services, Division of Behavioral Health, will lead the project in collaboration with ongoing efforts with the South Dakota Department of Health (through Centers for Disease Control Data-Driven Prevention Initiative funding focused on prescription drug overdose), the Division's State SBIRT (Screening, Brief Intervention, and Referral to Treatment) Implementation grant, and community providers to identify, leverage, and enhance community-based resources in the areas of prevention, treatment, recovery, and peer support services. The project will be led by Kaitlyn Broesder, with enhanced project management through a contracted State Opioid Coordinator, supported by integration with a multidisciplinary team - the Opioid Abuse Advisory Committee - and key personnel to assess, identify, and support the implementation strategies that directly address these broad goals. Key outcomes of this two-year project will include empowered and engaged communities with increased awareness of the opioid and stimulant issues within our state, culturally responsive materials and strategies that can impact our most vulnerable populations, better equipped first responders to incidences of opioid overdose, extensive multidisciplinary training and curriculum supports in evidence-based prevention and treatment models, continued supports for enhanced access to Medication-Assisted Treatment through telehealth, enhanced supports for virtual support 'hub' and 'spoke' models (teleECHO clinics) to support staffing of complex OUD cases, intensive case management services, continuation of care coordination services and integration of onsite supporting services (e.g. peer coaching, case management) within primary- or SUD treatment agency-based care sites/clinics. An estimated 5,810 individuals are projected to be served by the project through training, the provision of treatment and/or peer recovery support services, primary prevention programming for middle- and high-school youth/implementation of an evidence-based early intervention program and/or through connection/referral to community-based resources and providers. As an estimate for general public impact/outcomes and loved ones of patients impacted are difficult to predict, these numbers are not included. However, metrics and outcomes for access to the Resource Hotline, the AvoidOpioidSD media campaign and care coordination services for loved ones will be tracked on a monthly basis. The vision is to ensure every individual being served or serving patients with OUD or stimulant use disorder is impacted by this project in South Dakota.

Oregon State Opioid Response Grant Oregon focused it's 2020 SOR grant to serve rural and frontier regions of the state that have high prevalence of Opioid and stimulant use and hospitalization. In addition, focus is also on certain frontier and urban regions where overdose is high yet diagnosis is low due to lack of access to treatment. The population of focus would be rural communities and other underserved communities such as people of color, those with low English proficiency, pregnant women and women with children who have SUD. Prevention strategies are geared towards adolescents in school, treatment strategies are geared towards individuals in need for Medication Assisted Treatment, and recovery strategies are geared towards long term recovery. Oregon aims to serve at least 2000 individuals over the course of two years with the SOR grant.

The Utah State Stimulant and Opioid Response (UT SSOR) Grant, the Division of Substance Abuse and Mental Health (DSAMH) identifies youth ages 12-17 and adults ages 18 years and older, who have a current, or are at risk for an opioid use disorder (OUD) or stimulant use disorder as the population of focus. Priority populations will include pregnant women, individuals who use drugs intravenously, and people who are unfunded or uninsured. There will be UT SSOR projects throughout the state of Utah. The most recent death data available is from the state medical examiner's office indicates that in 2019 Utah had approximately 356 opioid-related overdose deaths. Opioids and psychostimulants, including methamphetamine, were listed on the health certificate as a contributing cause of death more often than any other drug types in 2019. There was a 38% increase in methamphetamine-involved overdose deaths from 2015 to 2019. Furthermore, methamphetamine was involved in 43% of all drug overdoses in Utah.

DBHDS proposes to serve 1,500 unique individuals with opioid and stimulant use disorder annually. Over one million people will receive recovery services, prevention messages, and training. Goal 1- Prevention: Provide prevention services to a minimum of 1,000,000 community members. Objective 1: By September 30, 2022, the communities’ ability to address opioid and stimulant misuse through community mobilization and coalition development will increase coalition members by 50%. Objective 2: By September 30, 2022, community awareness of opioid/stimulant misuse will be increased by 50% through a statewide campaign. Objective 3: By September 30, 2022, the number of medication safe storage and disposal units will be increased by 50%. Objective 4: By September 30, 2022, community capacity to address the traumatic impact of parent/caregiver addiction on children will increase by 75%. Objective 5: By September 30, 2022, targeted outreach to high priority and disparate populations will increase by 50%. Goal 2-Treatment: Increase the number of people who receive opioid and stimulant treatment by enhancing strategies to improve access to these services. Objective 1: Increase the number of individuals engaged in treatment who are receiving clinically appropriate treatment for opioids and stimulants use disorders by funding 40 CSBs. Objective 2: Increase the number of qualified buprenorphine prescribers by 10% among the CSBs. Objective 3: Increase the number of pregnant and postpartum women engaged in treatment services. Objective 4: Increase by 10% the number of CSB prescribers using telehealth consultation to provide clinical support and mentoring to medical professionals. Objective 5: Train a minimum of 3,000 individuals in the REVIVE! Program and provide them with naloxone to reverse opioid overdose. Objective 6: Collaborate with VADOC to engage a minimum of 550 individuals in treatment. Objective 7: Throughout the project period, work with two CSBs in rural catchment areas to establish transportation to OBOT services for consumers. Goal 3- Recovery Services: Increase the number of people receiving SUD recovery services by implementing a comprehensive strategy across all five DBHDS regions. Objective 1: Provide access to peer recovery services in emergency department settings in 40 Virginia hospitals. Objective 2: Increase access to PRS and other related resources by adding PRS funding at seven local health departments sites. Objective 3: Expand jail transition and drug court programming for people with SUDs by funding PRS in eight additional sites. Objective 4: Increase collegiate recovery programs from 5 to 8 universities and achieve a 25% increase in student participation. Objective 5: Broaden access, strengthen data tracking and industry minimum standards for recovery housing by providing funding to Virginia Association of Recovery Residences. Objective 6: Strengthen interconnection of regional CSB peer programming by funding one peer coordinator position in each of the five DBHDS regions. Objective 7: Increase access to family SUD recovery support by funding one family support program in each of the five DBHDS regions.